Table 1.
Definition | Patient group | Possible mechanisms |
---|---|---|
Inadequate response | Patients who fail to reach target SU on allopurinol |
Non-adherence Under dosing Partial resistance |
Partial resistance | Adherent patients on “standard” allopurinol doses (≤300mg daily) who fail to achieve target SU |
Impaired absorption Decreased conversion of allopurinol to oxypurinol Efficient renal excretion of oxypurinol Abnormality in XO structure and or function such that oxypurinol is rendered less effective Drug interactions |